U.S. Preventive Services Task Force

The U.S. Preventive Services Task Force has released a draft recommendation advocating for clinicians to prescribe preexposure prophylaxis to patients at increased risk for HIV.

There is still not enough evidence to make a recommendation for or against obstructive sleep apnea screening in asymptomatic adults, according to a statement from the U.S. Preventive Services Task Force.

The U.S. Preventive Services Task Force has released two final recommendations on the use of hormone therapy for the primary prevention of chronic conditions in postmenopausal people.

Healio and Cardiology Today have curated a list of the most-read news in cardiology of October 2022.

The U.S. Preventive Services Task Force has released a draft recommendation stating there is not enough evidence to advocate for or against skin cancer screening in asymptomatic adults and adolescents.

In August, the U.S. Preventive Services Task Force published a statement recommending statins for the primary prevention of CVD in patients aged 40 to 75 years with at least one CVD risk factor and 10% or greater 10-year risk for CVD.

The U.S. Preventive Services Task Force in August published a statement regarding the initiation of statin therapy for the primary prevention of atherosclerotic CVD.

From 2015 to 2019, most patients who were screened for lung cancer met 2013 U.S. Preventive Services Task Force criteria, but men, younger patients and those who previously smoked were less likely to be screened, a recent study found.

The United States Preventive Services Task Force has released final recommendation statements on anxiety, depression and suicide risk screening in children and adolescents.

The U.S. Preventive Services Task Force’s new recommendation statement on the use of statin therapy for primary prevention in adults aged 40 to 75 years with no history of CVD is similar to its 2016 recommendations.